ANALYSIS OF THE EFFICACY, SAFETY AND COST-EFFECTIVENESS OF DULOXETINE AND TRAZODONE TO TREAT NEUROPATHIC DIABETIC PAIN

被引：0
|
作者：
Silva, W. C. [1 ]
Crepalde, K. [1 ]
Guerra, A. A., Jr. [1 ]
Acurcio, F. A. [1 ]
机构：
[1] Univ Fed Minas Gerais, Sch Pharm, Dept Social Pharm, Post Grad Program, Belo Horizonte, MG, Brazil
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2015年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
107
引用
收藏
页码：A51 / A51
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of duloxetine versus routine treatment for US patients with diabetic peripheral neuropathic pain
    Wu, Eric Q.
    Birnbaum, Howard G.
    Mareva, Milena N.
    Le, T. Kim
    Robinson, Rebecca L.
    Rosen, Amy
    Gelwicks, Steve
    JOURNAL OF PAIN, 2006, 7 (06): : 399 - 407
  • [2] The cost effectiveness of duloxetine in the treatment of diabetic peripheral neuropathic pain in the UK
    Beard, S.
    McCrink, L.
    Le, T. K.
    JOURNAL OF NEUROLOGY, 2006, 253 : 85 - 85
  • [3] Cost effectiveness of duloxetine in the treatment of diabetic peripheral neuropathic pain in the UK
    Beard, S. M.
    McCrink, L.
    Le, T. K.
    Garcia-Cebrian, A.
    Monz, B.
    Malik, R. A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (02) : 385 - 399
  • [4] Comparison of the Efficacy and Safety of Duloxetine and Gabapentin in Diabetic Peripheral Neuropathic Pain: A Meta-Analysis
    Jiang, Lanying
    Xiong, Yadan
    Cui, Jinguo
    CONTRAST MEDIA & MOLECULAR IMAGING, 2022, 2022
  • [5] Safety and Efficacy of Duloxetine in the Treatment of Diabetic Peripheral Neuropathic Pain in Older Patients
    Wasan, Ajay D.
    Ossanna, Melissa J.
    Raskin, Joel
    Wernicke, Joachim F.
    Robinson, Michael J.
    Hall, Jerry A.
    Edwards, Sara E.
    Lipsius, Sarah
    Meyers, Adam L.
    McCarberg, Bill H.
    CURRENT DRUG SAFETY, 2009, 4 (01) : 22 - 29
  • [6] The efficacy of duloxetine in reducing pain behavior in animal models of neuropathic pain accurately predicted the efficacy of duloxetine in diabetic peripheral neuropathic pain
    Hall, J. A.
    Iyengar, S.
    Perahia, D. G. S.
    Robinson, M. J.
    Ferdinand, S. J.
    Andorn, A. C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 98 - 99
  • [7] COST-EFFECTIVENESS OF MIROGABALIN FOR THE TREATMENT OF DIABETIC PERIPHERAL NEUROPATHIC PAIN IN TAIWAN
    Gray, E.
    Ye, X.
    Fleishman, D.
    Wang, S. J.
    Wang, Y. F.
    VALUE IN HEALTH, 2019, 22 : S275 - S275
  • [8] Cost-Effectiveness of Mirogabalin for the Treatment of Diabetic Peripheral Neuropathic Pain in Taiwan
    Gray, Emma
    Ye, Xin
    Wang, Yen-Feng
    Wang, Shuu-Jiun
    VALUE IN HEALTH REGIONAL ISSUES, 2021, 24 : 148 - 156
  • [9] Cost-effectiveness analysis of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy in Mexico
    Arreola-Ornelas, H.
    Dorantes-Aguilar, J.
    Garcia-Mollinedo, M. D. L.
    Rosado-Buzzo, A. A.
    Mould-Quevedo, J.
    Davila-Loaiza, G.
    VALUE IN HEALTH, 2008, 11 (03) : A17 - A18
  • [10] COST-EFFECTIVENESS ANALYSIS OF PREGABALIN IN THE TREATMENT OF CENTRAL NEUROPATHIC PAIN
    Karbusicka, M.
    Kolek, M.
    Duba, J.
    Vothova, P.
    Kova, Dolec J.
    VALUE IN HEALTH, 2015, 18 (07) : A670 - A670
12345